BOSTON, Feb. 4, 2017 /PRNewswire/ -- Mapi is a proud supporter of World Cancer Day 2017. Observed annually on February 4th, it is an initiative of the Union for International Cancer Control (UICC), focused on uniting the world's population in the fight against cancer. Per WHO's CANCER Today 2012 research, there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide.
At Mapi, Patients are at the heart of everything we do™. In our Patient Partner Workshops, people with cancer have expressed this loss of control when discussing potential participation in clinical studies. This is often communicated as misunderstandings about studies and perceptions that they are not offered participation because of their preconceived notions. "I didn't even know a clinical trial was an option for me. No one ever told me this. I'm feeling stunned right now that I could have made different decisions about my care." – 36-year-old Patient Partner Workshop participant.
Today on World Cancer Day 2017 (Saturday, 4 February), the world unites against this disease that knows no borders, is blind to race, religion, gender and age. At Mapi we believe that patients, researchers and care professionals should have the education and support they need to make decisions across the entire cancer journey. Through our patient research, Clinical Outcome Assessment (COA) databases, publications, presentations and our blogs we share our expertise with researchers and hope that our experience can accelerate prevention and treatment of Cancer.
On February 7th, Kelly Franchetti, RN, CCRN, CEN will present "Considering Diverse Patient Needs in Clinical Trials" at the Patient as Partners Conference in London. Clinical trials are often planned more for investigators and scientists than for patients. Mapi advocates the needs of patients from all of the geographic regions and cultures involved in the study. On March 8th a follow-up free Webinar on diversity in clinical trials is open for registration.
Today, the world's leading international cancer NGO, the Union for International Cancer Control (UICC), urges corporations to focus their business on products and services that improve public health. We at Mapi join the world to take action on cancer by making health and well-being commitments, participating in the social media activity and getting involved in awareness raising initiatives that are happening worldwide
Visit http://www.worldcancerday.org/ for more information on how the day is being marked around the world.
About Mapi: Patients are at the heart of our research
Mapi Group has over 40 years of experience supporting Life-Science companies in developing and implementing strategies for commercializing novel treatments through Strategic Regulatory Services, Pharmacovigilance, Market Access, Language Services, and gathering Real-World Evidence on Pharmaceuticals, Biologicals, and Medical Devices. Mapi Group is the premier provider of Health Research and Commercialization services to Life-Science companies enabling Market Authorization, Market Access and Market Adoption of novel therapeutics. Visit http://www.mapigroup.com for more information
Press contact: Media@mapigroup.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mapi-recognizes-world-cancer-day-300402199.html